Sector: Health Care.Industry: Biotechnology
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-1.330
REV2.562M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
RXRXRecursion Pharmaceuticals3.97%

Recursion Pharmaceuticals Frequently Asked Questions

Q

How do I buy Recursion Pharmaceuticals (RXRX) stock?

A

You can purchase shares of Recursion Pharmaceuticals (NASDAQ: RXRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Recursion Pharmaceuticals's (RXRX) competitors?

Q

What is the target price for Recursion Pharmaceuticals (RXRX) stock?

A

The latest price target for Recursion Pharmaceuticals (NASDAQ: RXRX) was reported by SVB Leerink on May 11, 2021. The analyst firm set a price target for 33.00 expecting RXRX to fall to within 12 months (a possible -9.42% downside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Recursion Pharmaceuticals (RXRX)?

A

The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $36.43 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Recursion Pharmaceuticals (RXRX) pay a dividend?

A

There are no upcoming dividends for Recursion Pharmaceuticals.

Q

When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?

A
Recursion Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Recursion Pharmaceuticals (RXRX) going to split?

A

There is no upcoming split for Recursion Pharmaceuticals.

Q

What sector and industry does Recursion Pharmaceuticals (RXRX) operate in?

A

Recursion Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.